In the past week, ELV stock has gone up by 0.41%, with a monthly gain of 2.88% and a quarterly plunge of -7.44%. The volatility ratio for the week is 1.26%, and the volatility levels for the last 30 days are 2.12% for Elevance Health Inc The simple moving average for the last 20 days is -0.20% for ELV’s stock, with a simple moving average of -9.33% for the last 200 days.
Is It Worth Investing in Elevance Health Inc (NYSE: ELV) Right Now?
The price-to-earnings ratio for Elevance Health Inc (NYSE: ELV) is above average at 15.07x. The 36-month beta value for ELV is also noteworthy at 0.62. There are mixed opinions on the stock, with 13 analysts rating it as a “buy,” 5 rating it as “overweight,” 4 rating it as “hold,” and 0 rating it as “sell.”
The public float for ELV is 225.55M, and at present, short sellers hold a 0.98% of that float. The average trading volume of ELV on June 13, 2025 was 1.80M shares.
ELV) stock’s latest price update
The stock price of Elevance Health Inc (NYSE: ELV) has jumped by 1.39 compared to previous close of 380.93. Despite this, the company has seen a gain of 0.41% in its stock price over the last five trading days. globenewswire.com reported 2025-06-12 that Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In Elevance To Contact Him Directly To Discuss Their Options
Analysts’ Opinion of ELV
Many brokerage firms have already submitted their reports for ELV stocks, with Robert W. Baird repeating the rating for ELV by listing it as a “Neutral.” The predicted price for ELV in the upcoming period, according to Robert W. Baird is $529 based on the research report published on April 15, 2025 of the current year 2025.
Argus, on the other hand, stated in their research note that they expect to see ELV reach a price target of $450. The rating they have provided for ELV stocks is “Buy” according to the report published on March 17th, 2025.
Stephens gave a rating of “Equal-Weight” to ELV, setting the target price at $440 in the report published on January 22nd of the current year.
ELV Trading at -5.12% from the 50-Day Moving Average
After a stumble in the market that brought ELV to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -31.91% of loss for the given period.
Insider Trading
Reports are indicating that there were more than several insider trading activities at ELV starting from Kaye Mark, who sale 4,588 shares at the price of $424.82 back on Apr 24 ’25. After this action, Kaye Mark now owns 18,977 shares of Elevance Health Inc, valued at $1,949,074 using the latest closing price.
Kaye Mark, the Officer of Elevance Health Inc, proposed sale 4,588 shares at $424.81 during a trade that took place back on Apr 24 ’25, which means that Kaye Mark is holding shares at $1,949,051 based on the most recent closing price.
Stock Fundamentals for ELV
Current profitability levels for the company are sitting at:
- 0.04 for the present operating margin
- 0.63 for the gross margin
The net margin for Elevance Health Inc stands at 0.03. The total capital return value is set at 0.1. Equity return is now at value 14.24, with 5.11 for asset returns.
Based on Elevance Health Inc (ELV), the company’s capital structure generated 0.41 points at debt to capital in total, while cash flow to debt ratio is standing at 0.16. The debt to equity ratio resting at 0.71. The interest coverage ratio of the stock is 6.23.
Currently, EBITDA for the company is 9.09 billion with net debt to EBITDA at 2.23. When we switch over and look at the enterprise to sales, we see a ratio of 0.6. The receivables turnover for the company is 15.49for trailing twelve months and the total asset turnover is 1.53. The liquidity ratio also appears to be rather interesting for investors as it stands at 1.43.
Conclusion
In summary, Elevance Health Inc (ELV) has had a mixed performance as of late. Analysts have mixed opinions on the stock, with some viewing it as a “buy” and others as a “hold”. It’s important to note that the stock is currently trading at a significant distance from its 50-day moving average and its 52-week high.
